Exosomes Market Research Report Information By Products & Services (Kits & Reagents, Instruments, and Services), By Application (Diagnostic and Therapeutic), By Indication (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL EXOSOMES MARKET, BY PRODUCTS & SERVICES

6.1. Overview

6.2. Kits & Reagents

6.3. Instruments

6.4. Services

7. GLOBAL EXOSOMES MARKET, BY APPLICATION

7.1. Overview

7.2. Diagnostic

7.3. Therapeutic

8. GLOBAL EXOSOMES MARKET, BY INDICATION

8.1. Overview

8.2. Cancer

8.3. Neurodegenerative Diseases

8.4. Cardiovascular Diseases

8.5. Infectious Diseases

8.6. Others

9. GLOBAL EXOSOMES MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Exosomes Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Exosomes Market

10.7. Key Developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure, 2023

11. COMPANY PROFILES

11.1. Danaher (Beckman Coulter Inc.)

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Diagenode Inc.

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. FUJIFILM HOLDINGS CORPORATION

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Hitachi Chemical Diagnostics Inc.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Lonza

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. MBL INTERNATIONAL

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Miltenyi Biotec

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Novus Biologicals

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Qiagen

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Thermo Fisher Scientific Inc.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL EXOSOMES MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL EXOSOMES MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 9 US: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 10 US: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 11 US: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 12 CANADA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 13 CANADA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 CANADA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 10 ITALY: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 11 ITALY: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 ITALY: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 16 UK: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 17 UK: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 UK: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 28 CHINA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 29 CHINA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 30 CHINA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 31 INDIA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 32 INDIA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 33 INDIA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: EXOSOMES MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: EXOSOMES MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: EXOSOMES MARKET, BY INDICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL EXOSOMES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL EXOSOMES MARKET

FIGURE 4 GLOBAL EXOSOMES MARKET, SHARE (%), BY PRODUCTS & SERVICES, 2023

FIGURE 5 GLOBAL EXOSOMES MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 6 GLOBAL EXOSOMES MARKET, SHARE (%), BY INDICATION, 2023

FIGURE 7 GLOBAL EXOSOMES MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: EXOSOMES MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: EXOSOMES MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: EXOSOMES MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: EXOSOMES MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL EXOSOMES MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 DANAHER (BECKMAN COULTER INC.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 DANAHER (BECKMAN COULTER INC.): SWOT ANALYSIS

FIGURE 15 DIAGENODE INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 DIAGENODE INC.: SWOT ANALYSIS

FIGURE 17 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS

FIGURE 19 HITACHI CHEMICAL DIAGNOSTICS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 HITACHI CHEMICAL DIAGNOSTICS INC.: SWOT ANALYSIS

FIGURE 21 LONZA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 LONZA: SWOT ANALYSIS

FIGURE 23 MBL INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 MBL INTERNATIONAL: SWOT ANALYSIS

FIGURE 25 MILTENYI BIOTEC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 MILTENYI BIOTEC: SWOT ANALYSIS

FIGURE 27 NOVUS BIOLOGICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 NOVUS BIOLOGICALS: SWOT ANALYSIS

FIGURE 29 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 QIAGEN: SWOT ANALYSIS

FIGURE 31 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS